OpenLB
Open Library of Bioscience
Advanced Search
Clinical journal of the American Society of Nephrology : CJASN
Oct 01, 2024;19 (10): 1240-1252.

Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study.

Lorenza Magagnoli, Mario Cozzolino, Marie Evans, Fergus J Caskey, Friedo W Dekker, Claudia Torino, Maciej Szymczak, Christiane Drechsler, Maria Pippias, Antonio Vilasi, Roemer J Janse, Magdalena Krajewska, Vianda S Stel, Kitty J Jager, Nicholas C Chesnaye, EQUAL study investigators
Author Information
  1. Lorenza Magagnoli: Department of Health Sciences, University of Milan, Milano, Italy. ORCID
  2. Mario Cozzolino: Department of Health Sciences, University of Milan, Milano, Italy. ORCID
  3. Marie Evans: Renal Unit, Department of Clinical Intervention and technology (CLINTEC), Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. ORCID
  4. Fergus J Caskey: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. ORCID
  5. Friedo W Dekker: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. ORCID
  6. Claudia Torino: IFC-CNR, Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy. ORCID
  7. Maciej Szymczak: Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland. ORCID
  8. Christiane Drechsler: Division of Nephrology, University Hospital of W��rzburg, W��rzburg, Germany. ORCID
  9. Maria Pippias: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. ORCID
  10. Antonio Vilasi: IFC-CNR, Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, Italy.
  11. Roemer J Janse: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. ORCID
  12. Magdalena Krajewska: Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland. ORCID
  13. Vianda S Stel: Medical Informatics, University of Amsterdam, Amsterdam, The Netherlands. ORCID
  14. Kitty J Jager: Medical Informatics, University of Amsterdam, Amsterdam, The Netherlands. ORCID
  15. Nicholas C Chesnaye: Medical Informatics, University of Amsterdam, Amsterdam, The Netherlands. ORCID
PMID: 39037951 DOI: 10.2215/CJN.0000000000000510

Abstract

No abstract text available.

References

  1. Fletcher B, Damery S, Aiyegbusi OL, et al. Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLoS Med. 2022;19(4):e1003954. doi: 10.1371/journal.pmed.1003954 [DOI: 10.1371/journal.pmed.1003954]
  2. Almutary H, Bonner A, Douglas C. Symptom burden in chronic kidney disease: a review of recent literature. J Ren Care. 2013;39(3):140���150. doi: 10.1111/j.1755-6686.2013.12022.x [DOI: 10.1111/j.1755-6686.2013.12022.x]
  3. Caplin B, Kumar S, Davenport A. Patients' perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant. 2011;26(8):2656���2663. doi: 10.1093/ndt/gfq763 [DOI: 10.1093/ndt/gfq763]
  4. Murphy EL, Murtagh FEM, Carey I, Sheerin NS. Understanding symptoms in patients with advanced chronic kidney disease managed without dialysis: use of a short patient-completed assessment tool. Nephron Clin Pract. 2009;111(1):C74���C80. doi: 10.1159/000183177 [DOI: 10.1159/000183177]
  5. Murtagh FEM, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82���99. doi: 10.1053/j.ackd.2006.10.001 [DOI: 10.1053/j.ackd.2006.10.001]
  6. Murtagh FEM, Addington-Hall JM, Edmonds PM, et al. Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. J Palliat Med. 2007;10(6):1266���1276. doi: 10.1089/jpm.2007.0017 [DOI: 10.1089/jpm.2007.0017]
  7. Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol. 2005;16(8):2487���2494. doi: 10.1681/ASN.2005020157 [DOI: 10.1681/ASN.2005020157]
  8. Voskamp PWM, van Diepen M, Evans M, et al. The impact of symptoms on health-related quality of life in elderly pre-dialysis patients: effect and importance in the EQUAL study. Nephrol Dial Transplant. 2019;34(10):1707���1715. doi: 10.1093/ndt/gfy167 [DOI: 10.1093/ndt/gfy167]
  9. Morton RL, Tong A, Howard K, Snelling P, Webster AC. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010;340:c112. doi: 10.1136/bmj.c112 [DOI: 10.1136/bmj.c112]
  10. Cabrera VJ, Hansson J, Kliger AS, Finkelstein FO. Symptom management of the patient with CKD: the role of dialysis. Clin J Am Soc Nephrol. 2017;12(4):687���693. doi: 10.2215/CJN.01650216 [DOI: 10.2215/CJN.01650216]
  11. Members KB. Chapter 5: referral to specialists and models of care. Kidney Int Suppl (2011). 2013;3(1):112���119. doi: 10.1038/kisup.2012.68 [DOI: 10.1038/kisup.2012.68]
  12. de Rooij ENM, Meuleman Y, de Fijter JW, et al. Symptom burden before and after dialysis initiation in older patients. Clin J Am Soc Nephrol. 2022;17(12):1719���1729. doi: 10.2215/CJN.09190822 [DOI: 10.2215/CJN.09190822]
  13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(113):S1���S130. doi: 10.1038/ki.2009.188 [DOI: 10.1038/ki.2009.188]
  14. Komaba H, Zhao JH, Yamamoto S, et al. Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS. J Cachexia Sarcopenia Muscle. 2021;12(4):855���865. doi: 10.1002/jcsm.12722 [DOI: 10.1002/jcsm.12722]
  15. Ribeiro MCCB, Vogt BP, Vannini FCD, Caramori JCT. Role of parathyroid hormone in anorexia on maintenance hemodialysis patients. Clin Nutr ESPEN. 2019;34:137���141. doi: 10.1016/j.clnesp.2019.07.008 [DOI: 10.1016/j.clnesp.2019.07.008]
  16. Golan E, Haggiag I, Os P, Bernheim J. Calcium, parathyroid hormone, and vitamin D: major determinants of chronic pain in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(8):1374���1380. doi: 10.2215/CJN.00680109 [DOI: 10.2215/CJN.00680109]
  17. Malindretos P, Sarafidis P, Lazaridis A, Nikolaidis P. A study of the association of higher parathormone levels with health-related quality of life in hemodialysis patients. Clin Nephrol. 2012;77(3):196���203. doi: 10.5414/Cn107030 [DOI: 10.5414/Cn107030]
  18. Levy AR, Xing S, Brunelli SM, et al. Symptoms of secondary hyperparathyroidism in patients receiving maintenance hemodialysis: a prospective cohort study. Am J Kidney Dis. 2020;75(3):373���383. doi: 10.1053/j.ajkd.2019.07013 [DOI: 10.1053/j.ajkd.2019.07013]
  19. Cengic B, Resic H, Spasovski G, Avdic E, Alajbegovic A. Quality of sleep in patients undergoing hemodialysis. Int Urol Nephrol. 2012;44(2):557���567. doi: 10.1007/s11255-010-9881-x [DOI: 10.1007/s11255-010-9881-x]
  20. Sabbatini M, Minale B, Crispo A, et al. Insomnia in maintenance haemodialysis patients. Nephrol Dial Transplant. 2002;17(5):852���856. doi:DOI. 10.1093/ndt/17.5.852 [DOI: 10.1093/ndt/17.5.852]
  21. Noordzij M, Boeschoten EW, Bos WJ, et al. Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. Nephrol Dial Transplant. 2007;22(10):2944���2949. doi: 10.1093/ndt/gfm319 [DOI: 10.1093/ndt/gfm319]
  22. Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69(9):1626���1632. doi: 10.1038/sj.ki.5000251 [DOI: 10.1038/sj.ki.5000251]
  23. Pisoni RL, Wikstr��m B, Elder SJ, et al. Pruritus in haemodialysis patients:: international results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495���3505. doi: 10.1093/ndt/gfl461 [DOI: 10.1093/ndt/gfl461]
  24. Neves PDMM, Graciolli FG, Oliveira IB, Bridi RA, Moys��s RMA, Elias RM. Effect of mineral and bone metabolism on restless legs syndrome in hemodialysis patients. J Clin Sleep Med. 2017;13(1):89���94. doi: 10.5664/jcsm.6396 [DOI: 10.5664/jcsm.6396]
  25. Sabry AA, Abo-Zenah H, Wafa E, et al. Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transpl. 2010;21(2):300���305. PMID: 20228517
  26. Ezzat H, Mohab A. Prevalence of sleep disorders among ESRD patients. Ren Fail. 2015;37(6):1013���1019. doi: 10.3109/0886022x.2015.1044401 [DOI: 10.3109/0886022x.2015.1044401]
  27. Unruh ML, Hartunian MG, Chapman MM, Jaber BL. Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol. 2003;59(4):280���288. doi: 10.5414/cnp59280 [DOI: 10.5414/cnp59280]
  28. Duque MI, Thevarajah S, Chan YH, Tuttle AB, Freedman BI, Yosipovitch G. Uremic pruritus is associated with higher Kt/V and serum calcium concentration. Clin Nephrol. 2006;66(3):184���191. doi: 10.5414/cnp66184 [DOI: 10.5414/cnp66184]
  29. Jager KJ, Ocak G, Drechsler C, et al. The EQUAL study: a European study in chronic kidney disease stage 4 patients. Nephrol Dial Transplant. 2012;27(suppl 3):27���31. doi: 10.1093/ndt/gfs277 [DOI: 10.1093/ndt/gfs277]
  30. Weisbord SD, Fried LF, Arnold RM, et al. Development of a symptom assessment instrument for chronic hemodialysis patients: the dialysis symptom index. J Pain Symptom Manag. 2004;27(3):226���240. doi: 10.1016/j.jpainsymman.2003.07.004 [DOI: 10.1016/j.jpainsymman.2003.07.004]
  31. Janmaat CJ, van Diepen M, Meuleman Y, et al. Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study. Nephrol Dial Transplant. 2021;36(5):862���870. doi: 10.1093/ndt/gfz277 [DOI: 10.1093/ndt/gfz277]
  32. van de Luijtgaarden MWM, Caskey FJ, Wanner C, et al. Uraemic symptom burden and clinical condition in women and men of ���65years of age with advanced chronic kidney disease: results from the EQUAL study. Nephrol Dial Transplant. 2019;34(7):1189���1196. doi: 10.1093/ndt/gfy155 [DOI: 10.1093/ndt/gfy155]
  33. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol. 1995;57(1):289���300. doi: 10.1111/j.2517-6161.1995.tb02031.x [DOI: 10.1111/j.2517-6161.1995.tb02031.x]
  34. Baron RM, Kenny DA. The moderator-mediator variable distinction in social-psychological research - conceptual, strategic, and statistical considerations. J Personal Social Psychol. 1986;51(6):1173���1182. doi: 10.1037/0022-3514.51.6.1173 [DOI: 10.1037/0022-3514.51.6.1173]
  35. Chertow GM, Lu ZJ, Xu X, et al. Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols. Hemodial Int. 2012;16(2):188���197. doi: 10.1111/j.1542-4758.2011.00642.x [DOI: 10.1111/j.1542-4758.2011.00642.x]
  36. Zhang DL, Chen S, Gao MZ, et al. Ultrasound-guided radiofrequency ablation: a new attempt to the treatment of refractory hyperparathyroidism secondary to chronic kidney disease. Kidney Int Rep. 2022;7(2):282���288. doi: 10.1016/j.ekir.2021.11.038 [DOI: 10.1016/j.ekir.2021.11.038]
  37. Wang L, Xin MH, Ma Y, et al. Effect of parathyroidectomy on quality of life among patients undergoing dialysis. Int J Gen Med. 2022;15:1185���1192. doi: 10.2147/ijgm.s354145 [DOI: 10.2147/ijgm.s354145]
  38. Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int. 2005;68(4):1793���1800. doi: 10.1111/j.1523-1755.2005.00596.x [DOI: 10.1111/j.1523-1755.2005.00596.x]
  39. Jimeno-Fraile J, Cao H, Sancho-Insenser J, Lorente-Poch L, Sitges-Serra A. Muscle strength, physical performance, and metabolic changes after subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery. 2021;169(4):846���851. doi: 10.1016/j.surg.2020.10.002 [DOI: 10.1016/j.surg.2020.10.002]
  40. Santos RSS, Coelho FMS, da Silva BC, et al. Parathyroidectomy improves restless leg syndrome in patients on hemodialysis. PLoS One. 2016;11(5):e0155835. doi: 10.1371/journal.pone.0155835 [DOI: 10.1371/journal.pone.0155835]
  41. Chou FF, Chen JB, Hsieh KC, Liou CW. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. Surgery. 2008;143(4):526���532. doi: 10.1016/j.surg.2007.11.019 [DOI: 10.1016/j.surg.2007.11.019]
  42. Bakthavatchalu P, Padubidri Kombettu A, Betkerur J, Kushalappa PA, Chetan CS. Profile OF SKIN changes and its association with biochemical parameters in haemodialysis patients. J Evol Med Dental Sci. 2016;5(97):7120���7124. doi: 10.14260/jemds/2016/1612 [DOI: 10.14260/jemds/2016/1612]
  43. Bolanos CG, Pham NM, Mair RD, Meyer TW, Sirich TL. Metabolomic analysis of uremic pruritus in patients on hemodialysis. PLoS One. 2021;16(2):e0246765. doi: 10.1371/journal.pone.0246765 [DOI: 10.1371/journal.pone.0246765]
  44. Dyachenko P, Shustak A, Rozenman D. Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol. 2006;45(6):664���667. doi: 10.1111/j.1365-4632.2005.02592.x [DOI: 10.1111/j.1365-4632.2005.02592.x]
  45. Hu TH, Wang B, Liao XH, Wang SX. Clinical features and risk factors of pruritus in patients with chronic renal failure. Exp Ther Med. 2019;18(2):964���971. doi: 10.3892/etm.2019.7588 [DOI: 10.3892/etm.2019.7588]
  46. Makhlough A, Emadi N, Sedighi O, Khademloo M, Bicmohamadi AR. Relationship between serum intact parathyroid hormone and pruritus in hemodialysis patients. Iranian J Kidney Dis. 2013;7(1):42���46. PMID: 23314141
  47. Shirazian S, Kline M, Sakhiya V, et al. Longitudinal predictors of uremic pruritus. J Ren Nutr. 2013;23(6):428���431. doi: 10.1053/j.jrn.2013.08.002 [DOI: 10.1053/j.jrn.2013.08.002]
  48. Solak B, Acikgoz SB, Sipahi S, Erdem T. Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients. Int Urol Nephrol. 2016;48(4):585���591. doi: 10.1007/s11255-015-1208-5 [DOI: 10.1007/s11255-015-1208-5]
  49. Deme S, Fisseha B, Kahsay G, Melese H, Alamer A, Ayhualem S. Musculoskeletal disorders and associated factors among patients with chronic kidney disease attending at saint Paul hospital, Addis Ababa, Ethiopia. Int J Nephrol Renovasc Dis. 2021;14:291���300. doi: 10.2147/ijnrd.s319991 [DOI: 10.2147/ijnrd.s319991]
  50. Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1���59. doi: 10.1016/j.kisu.2017.04.001 [DOI: 10.1016/j.kisu.2017.04.001]
  51. Ketteler M, Bover J, Mazzaferro S. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal 2022s. Nephrol Dial Transplant. 2022;38(6):1397���1404. doi: 10.1093/ndt/gfac236 [DOI: 10.1093/ndt/gfac236]
  52. Magagnoli L, Cozzolino M, Caskey FJ, et al. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study. Nephrol Dial Transplant. 2023;38(11):2562���2575. doi: 10.1093/ndt/gfad100 [DOI: 10.1093/ndt/gfad100]
  53. Momose A, Kudo S, Sato M, et al. Calcium ions are abnormally distributed in the skin of haemodialysis patients with uraemic pruritus. Nephrol Dial Transplant. 2004;19(8):2061���2066. doi: 10.1093/ndt/gfh287 [DOI: 10.1093/ndt/gfh287]
  54. Elizabeth S. In: Rosen CJ, ed. Clinical Manifestations of Hypercalcemia. UpToDate; 2022.
  55. David G. In: Rosen CJ, ed. Clinical Manifestations of Hypocalcemia. UpToDate; 2022.
  56. Aggarwal H, Jain D, Bhavikatti A. Cognitive dysfunction in patients with chronic kidney disease. Saudi J Kidney Dis Transplant. 2020;31(4):796���804. doi: 10.4103/1319-2442.292313 [DOI: 10.4103/1319-2442.292313]
  57. Aggarwal H, Jain D, Dabas G, Yadav R. Prevalence of depression, anxiety and insomnia in chronic kidney disease patients and their co-relation with the demographic variables. Prilozi. 2017;38(2):35���44. doi: 10.1515/prilozi-2017-0020 [DOI: 10.1515/prilozi-2017-0020]
  58. Massy ZA, Chesnaye NC, Larabi IA, et al. The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease. Clin Kidney J. 2022;15(4):798���807. doi: 10.1093/ckj/sfab262 [DOI: 10.1093/ckj/sfab262]
  59. ten Bolscher M, Netelenbos JC, Barto R, Van Buuren LM, Van der Vijgh WJF. Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat. J Bone Mineral Res. 1999;14(7):1197���1202. doi: 10.1359/jbmr.1999.14.7.1197 [DOI: 10.1359/jbmr.1999.14.7.1197]
  60. Faroqui S, Levi M, Soleimani M, Amlal H. Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int. 2008;73(10):1141���1150. doi: 10.1038/ki.2008.33 [DOI: 10.1038/ki.2008.33]
  61. Carrillo-L��pez N, Rom��n-Garc��a P, Rodr��guez-Rebollar A, Fern��ndez-Mart��n JL, Naves-D��az M, Cannata-And��a JB. Indirect regulation of PTH by estrogens may require FGF23. J Am Soc Nephrol. 2009;20(9):2009���2017. doi: 10.1681/ASN.2008121258 [DOI: 10.1681/ASN.2008121258]
  62. Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harbor Perspect Med. 2018;8(1):a031211. doi: 10.1101/cshperspect.a031211 [DOI: 10.1101/cshperspect.a031211]
  63. Jhee JH, Kim H, Park S, et al. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS One. 2017;12(2):e0171009. doi: 10.1371/journal.pone.0171009 [DOI: 10.1371/journal.pone.0171009]
  64. Yavuz YC, Biyik Z, Ozkul D, et al. Association of depressive symptoms with 25(OH) vitamin D in hemodialysis patients and effect of gender. Clin Exp Nephrol. 2020;24(1):63���72. doi: 10.1007/s10157-019-01794-7 [DOI: 10.1007/s10157-019-01794-7]

Grants

  1. /European Renal Association (ERA), Swedish Medical Association, Stockholm County Council ALF Medicine, Center for Innovative Medicine,Italian Society of Nephrology (SIN-Reni), Dutch Kidney Foundation, Young Investigators grant, National Institute for Health Research
Journal Article

Word Cloud

Created with Highcharts 10.0.0ChronicKidneyAssociationDisease-MineralBoneDisorderBiomarkersSymptomBurdenOlderPatientsAdvancedDisease:ResultsEQUALStudy

Similar Articles

Cited By (1)